Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU) by Super User in News on March 29, 2020 https://esmoopen.bmj.com/content/esmoopen/5/2/e000666.full.pdf Leave your comments Submit comment Submit comment Comments No comments found Powered by Komento
Leave your comments